Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Aug 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for i-GENTIC
- ·The full record, as it builds
Funding rounds
No funding rounds for i-GENTIC are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About i-GENTIC
Developer of autonomous governance technology intended to ensure compliance across healthcare, finance, and enterprise systems. The company's agentic aI tracks drift, flags ethical risks, enforces HIPAA, GDPR, and regional laws, and applies defense logic in real time, enabling organizations to achieve scalable, secure, and adaptive governance solutions.
- Sector
- Information Technology
- HQ
- Palo Alto, CA, United States
- Founded
- 2024
- Website
- igenticai.com/
- Ownership
- Privately Held (backing)
i-GENTIC doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in i-GENTIC shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on i-GENTIC in its N-PORT filings yet. We sweep new filings monthly.